ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 2.73X leverage
Performance
- Low
- ₹1,165
- High
- ₹1,201
- 52 Week Low
- ₹1,057
- 52 Week High
- ₹2,248
- Open Price₹1,169
- Previous Close₹1,162
- Volume195,783
- 50 DMA₹1,507.41
- 100 DMA₹1,620.12
- 200 DMA₹1,668.04
Investment Returns
- Over 1 Month -32.22%
- Over 3 Month -32.88%
- Over 6 Month -36.91%
- Over 1 Year -21.66%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 680.4
- PEG Ratio
- 6
- Market Cap Cr
- 13,677
- P/B Ratio
- 2.3
- Average True Range
- 82.37
- EPS
- 2.67
- Dividend Yield
- 0
- MACD Signal
- -135.34
- RSI
- 32.79
- MFI
- 15.13
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,193.20
+
30.8
(2.65%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹1,325.89
- 50 Day
- ₹1,507.41
- 100 Day
- ₹1,620.12
- 200 Day
- ₹1,668.04
Resistance and Support
1186.4
- R3 1,244.70
- R2 1,223.00
- R1 1,208.10
- S1 1,171.50
- S2 1,149.80
- S3 1,134.90
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,193 As on 11 February, 2026 | 02:33
The Market Cap of OneSource Specialty Pharma is ₹13676.6 Cr As on 11 February, 2026 | 02:33
The P/E ratio of OneSource Specialty Pharma is 680.4 As on 11 February, 2026 | 02:33
The PB ratio of OneSource Specialty Pharma is 2.3 As on 11 February, 2026 | 02:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.